Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.600
-0.140 (-8.05%)
At close: Dec 20, 2024, 4:00 PM
1.550
-0.050 (-3.13%)
After-hours: Dec 20, 2024, 7:01 PM EST

Mersana Therapeutics Market Cap

Mersana Therapeutics has a market cap or net worth of $197.65 million as of December 20, 2024. Its market cap has decreased by -19.65% in one year.

Market Cap
197.65M
Enterprise Value
74.01M
1-Year Change
-19.65%
Ranking
Category
Stock Price
$1.60

Market Cap Chart

Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.04M to $197.65M, a decrease of -37.66%. That is a compound annual growth rate of -6.12%.

History

DateMarket Cap% Change
Dec 20, 2024197.65M-29.35%
Dec 29, 2023279.75M-52.15%
Dec 30, 2022584.67M30.71%
Dec 31, 2021447.29M-75.46%
Dec 31, 20201.82B564.32%
Dec 31, 2019274.37M190.08%
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Cardiff Oncology 229.59M
Nautilus Biotechnology 226.02M
Ocugen 223.70M
Alpha Tau Medical 218.51M
Fulcrum Therapeutics 217.37M
Precigen 212.56M
Inhibikase Therapeutics 212.33M
LifeMD 212.23M
Market Cap Rankings